Adaptin Bio (APTN) Interest Expenses (2024 - 2026)

Adaptin Bio has disclosed Interest Expenses across 3 years of filings, most recently posting $1943.0 for Q1 2026.

• Quarterly Interest Expenses fell 97.33% year-over-year to $1943.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1943.0 (down 99.48% YoY) and the FY2025 annual result came in at $72659.0, down 78.7% from the prior year.
• Interest Expenses retreated to $1943.0 in Q1 2026, from $72659.0 in the prior quarter.
• Across five years, Interest Expenses topped out at $145887.0 in Q4 2024 and bottomed at $1943.0 in Q1 2026.
• The 3-year median for Interest Expenses is $60852.0 (2024), against an average of $69275.0.
• Year-over-year, Interest Expenses jumped 83.65% in 2025 and plunged 97.33% in 2026.
• Adaptin Bio's Interest Expenses stood at $145887.0 in 2024, then sank by 50.2% to $72659.0 in 2025, then plunged by 97.33% to $1943.0 in 2026.
• According to Business Quant data, Interest Expenses over the past three periods registered $1943.0, $72659.0, and $145887.0 for Q1 2026, Q1 2025, and Q4 2024 respectively.